BUL/TEVA (BUL/TEVA)

Bulgarian Stock Exchange: BUL/TEVA · EUR

€35.3

+0.30 (+0.9%)· Recorded snapshot

Market cap	41.8B
Revenue (ttm)	15.2B
Net income (ttm)	618M
EPS (ttm)	€0.54
P/E (trailing)	65.5x
P/E (forward)	14.0x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 15.2B
Net income (ttm): 618M
EPS (ttm): €0.54
P/E (trailing): 65.5x
P/E (forward): 14.0x
Market cap: 41.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E14

P25 n/aP50 n/aP75 n/a

Trailing P/E65.5

P25 n/aP50 n/aP75 n/a

ROE9.7

P25 n/aP50 n/aP75 n/a

ROIC15.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BUL/TEVA indicators

Market & fundamental data

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Israel
Country code	BG
Earnings date	2026-11-03
Employees	32,008
Employees change	-2,844
Employees growth	-7.97%
Enterprise value	EUR 53.7B
Exchange	Bulgarian Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-10
Fiscal year end	December
Founded	1901
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	IL0006290147
Last refreshed	2026-10-29
Market cap	EUR 41.8B
Next earnings date	2026-11-03
Price	EUR 35.30
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-05
Symbol	bul/TEVA
Website	https://www.tevapharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	1.53%
EV/Earnings	86.85x
EV/EBIT	18.17x
EV/EBITDA	13.55x
EV/FCF	45.52x
EV/Sales	3.45x
FCF / EV yield	2.2%
FCF yield	2.82%
Forward P/E	14x
Graham number	8.20753
Graham upside	-76.75%
P/(FCF - SBC) ratio	40.49x
P/(OCF - SBC) ratio	27.6x
P/B ratio	6.15x
P/E ratio	65.53x
P/FCF ratio	35.44x
P/OCF ratio	25.15x
P/S ratio	2.76x
Price/EBITDA ratio	11.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	18.94%
EBITDA margin	24.65%
Effective tax rate	1.67%
FCF margin	7.61%
Gross margin	52.46%
Operating margin	18.94%
Pretax margin	4.15%
Profit margin	4.08%
Profit per employee	EUR 19,306
Profitable years	1
Revenue per employee	EUR 473,501
ROA	5.13%
ROA (5Y)	4.67%
ROCE	13.55%
ROE	9.69%
ROE (5Y)	-7.19%
ROIC	15.21%
ROIC (5Y)	12.12%
SBC / revenue	0.97%
Tax / revenue	0.07%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth 10Y	-8.71%
EPS growth years	1
FCF growth	51.35%
FCF growth (Q)	134.35%
FCF growth 3Y	4.72%
Gross profit growth	10.14%
Gross profit growth (Q)	2.43%
Gross profit growth 3Y	10.04%
Gross profit growth 5Y	3.49%
Net income growth years	1
OCF growth	36.55%
OCF growth (Q)	81.06%
OCF growth 10Y	-9.32%
OCF growth 3Y	3.84%
OCF growth 5Y	33.3%
Operating income growth	-6.31%
Operating income growth (Q)	-81.32%
Operating income growth 3Y	9.75%
Operating income growth 5Y	2.42%
Revenue growth	4.13%
Revenue growth (Q)	-0.81%
Revenue growth (QoQ)	4.02%
Revenue growth 10Y	-1.21%
Revenue growth 3Y	4.86%
Revenue growth 5Y	1.19%
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -482.3M
Depreciation and amortization	EUR 884.6M
EBIT	EUR 2.9B
EBITDA	EUR 3.7B
EPS	EUR 0.54
Financing cash flow	EUR -351M
Free cash flow	EUR 1.2B
Free cash flow minus SBC	EUR 1B
Gross profit	EUR 8B
Income taxes	EUR 10.5M
Investing cash flow	EUR 32.4M
Net borrowing	EUR -424.4M
Net cash flow	EUR 1.3B
Net income	EUR 618M
Operating cash flow minus SBC	EUR 1.5B
Operating income	EUR 2.9B
Revenue	EUR 15.2B
Stock-based compensation	EUR 147.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.68
Book value per share	EUR 5.82
Debt / EBITDA	3.84
Debt / equity	2.18
Debt / FCF	12.54
Goodwill	EUR 14.2B
Interest coverage	3.81
Long-term assets	EUR 22.6B
Long-term liabilities	EUR 14.1B
Net cash (debt)	EUR -11.6B
Net cash / market cap	-27.73%
Net debt / EBITDA	3.1
Net debt / equity	1.71
Net debt / FCF	9.83
Piotroski F-Score	7
Property, plant and equipment	EUR 3.8B
Shareholders' equity	EUR 6.8B
Tangible book value	EUR -10.1B
Tangible book value per share	EUR -8.66
Total assets	EUR 34.9B
Total cash	EUR 3.2B
Total debt	EUR 14.8B
Total liabilities	EUR 28.1B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.43
Current assets	EUR 12.3B
Current liabilities	EUR 14B
Current ratio	0.88
Inventory turnover	2.45
Net working capital	EUR -911.2M
Quick ratio	0.46
Working capital	EUR -1.7B
Working capital turnover	-26.9

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.24%
Shareholder yield	-2.24%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0.86%
52-week high	EUR 35.50
52-week high date	2026-09-30
52-week low	EUR 34.60
52-week low date	2026-10-01
All-time high	EUR 35.50
All-time high date	2026-09-30
All-time low	EUR 34.60
All-time low date	2026-10-01
Average volume	0
Change from 52-week high	-0.56%
Change from 52-week low	2.02%
Change from all-time high	-0.56%
Change from all-time low	2.02%
Change from open	0%
Day's gap	0.86%
High price	EUR 35.30
Low price	EUR 35.30
Monthly RSI	0
Open price	EUR 35.30
Previous close	EUR 35.00
RSI	0
Sharpe ratio	-1.8
Sortino ratio	-1.89
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.1B
Shares change (QoQ)	-1.19%
Shares change (YoY)	2.24%
Shares held by insiders	0.43%
Shares held by institutions	74.31%
Short ratio	4.9 days

Deeper analysis on BUL/TEVA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BUL/TEVA report

Is a complete BUL/TEVA research report available?

No complete published report is available for bul/TEVA (BUL/TEVA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BUL/TEVA (BUL/TEVA)

Price

Financial snapshot

Fair-value bridge

Latest news · BUL/TEVA

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All BUL/TEVA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BUL/TEVA

Frequently asked questions